Health

Australia cigarette plan facing new legal threat

A second global tobacco giant has flagged legal action over Australia's plain packaging plan for cigarettes, warning of violations of its intellectual property rights, a report said Saturday.

Diabetes

Daily text messages improve diabetes outcomes

(HealthDay)—Patients with poorly controlled diabetes have improvements in hemoglobin A1c and medication adherence and fewer trips to the emergency room after receiving daily text messages, according to a study published ...

Medical research

Rush for patents is choking US stem cell research

Cures for paralysis, blindness and diabetes could all be in reach with embryonic stem cell research, but the pursuit of medical progress is being choked by the US rush to secure patents, experts say.

Medications

EU-India trade deal could limit generics supply

(AP) -- AIDS patients in Africa are nervously awaiting the outcome of talks launched Friday between Europe and India on a new trade deal that could slash the world's supply of cheap generics.

Health

Philip Morris challenges plain packs in Australia

Global tobacco giant Philip Morris Tuesday stepped up its legal campaign against an Australian law banning logos and branding from cigarette packs, saying it had taken its case to the High Court.

Health

Australia fumes over smoking kangaroos

The Australian government on Friday hit out at British American Tobacco for using images of kangaroos to sell its cigarettes in Europe, telling the company to "get your hands off our icons".

Health

BAT challenges Australia cigarette packaging law

British American Tobacco on Thursday launched a High Court challenge against a law that will require plain packaging on cigarettes in Australia, claiming it infringes intellectual property rights.

Medications

India's global pharmacy role threatened by EU pact

(AP) -- Efforts by India and the European Union to strengthen trade are threatening India's ability to deliver lifesaving medicines to the world's poorest, analysts say as the two sides push through protracted negotiations ...

Medications

India licenses generic copy of patented Bayer drug

(AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.

page 1 from 4